Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-11-17

Clinical Trial Update: VIM DBS Respiratory Modulation: N-of-1 Trial

View source ↗

Summary

The N-of-1 trial examining VIM deep brain stimulation for respiratory modulation in essential tremor and dystonic tremor has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Oxford | Conditions: Essential Tremor, Dystonic Tremor | Status: WITHDRAWN